Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-20-000957
Filing Date
2020-02-12
Accepted
2020-02-12 16:15:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 EIGER BIOPHARMACEUTICALS, INC. p20-0314sc13ga.htm SC 13G/A 106648
  Complete submission text file 0000902664-20-000957.txt   108313
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

EIN.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

EIN.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 20604288
SIC: 2836 Biological Products, (No Diagnostic Substances)